top of page
Archetype has predicted clinical trial and real-world outcomes and discovered new and repurposed drugs for several diseases – including metastatic castrate-resistant prostate cancer (mCRPC), early-stage lung adenocarcinoma (esLUAD), metastatic melanoma, and idiopathic pulmonary fibrosis (IPF).
OUR PIPELINE
Therapeutic Area
Metastatic castration-resistant prostate cancer (mCRPC)
Early-stage lung
adenocarcinoma (esLUAD)
Metastatic melanoma
Idiopathic Pulmonary
Fibrosis (IPF)
Pancreatic cancer*
Exploration
Discovery
IND Enabling
In Vitro / In Vivo Validation
Clinical Development
*Disease areas for which Archetype computational models have not been completed yet
In Vitro / In Vivo Validation
In Vitro / In Vivo Validation
Discovery
Discovery
Exploration*
Therapeutic Area
Colorectal cancer
Exploration*
Colorectal cancer
bottom of page